OncoGenex Pharmaceuticals, Inc.
Industries:
  • Biotechnology
  • Medical/ Pharmaceuticals

Organization Profile

Market Performance

Latest News Releases

Filter Results
Save

OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013

May 2, 2013 4:01 PM

Save

OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer

May 1, 2013 6:30 AM

Save

OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment

April 30, 2013 8:01 AM

Save

OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013

April 25, 2013 4:01 PM

Save

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

April 23, 2013 4:01 PM

Save

OncoGenex Announces Plans for the Initiation of the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer

April 11, 2013 8:01 AM

Save

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

March 28, 2013 4:01 PM

Save

OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012

March 7, 2013 4:01 PM

Save

OncoGenex to Webcast Update on Clinical Development Program and Discussion of Fourth Quarter and Full Year 2012 Financial Results on Thursday, March 7, 2013

February 28, 2013 4:01 PM

See More